the michaelis menten equation

25
1 Exercise 15 Drug binding and investigation of the Michaelis Menten equation; pitfall of methods of linearisation

Upload: kato

Post on 07-Feb-2016

167 views

Category:

Documents


1 download

DESCRIPTION

Exercise 15 Drug binding and investigation of the Michaelis Menten equation; pitfall of methods of linearisation. The Michaelis Menten equation. Equation relating bound vs Free drug concentration. where Bound is the bound drug concentration, - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: The Michaelis Menten equation

1

Exercise 15Drug binding and investigation

of the Michaelis Menten equation; pitfall of methods of

linearisation

Page 2: The Michaelis Menten equation

2

The Michaelis Menten equation

SKm

SVVelocity

]max[

Page 3: The Michaelis Menten equation

3

Equation relating bound vs Free drug concentration

• where Bound is the bound drug concentration,• Bmax the maximal binding capacity of the transport

protein(s) • Kd the steady state dissociation constant.

– Kd is the free concentration of the drug for which the bound concentration is equal to Bmax/2.

– The inverse of Kd is Ka, the steady-state constant of affinity.• The unit of ka is the inverse of concentration. For example a Ka equal

to 5X109 M means that to obtain half the saturation of Bmax, one mole of ligand should be diluted in a volume of 5X109 L.

FreeKd

FreeBBound

max

Page 4: The Michaelis Menten equation

4

Free fraction vs free concentration

• In blood, a drug (ligand) coexists under two forms: bound [B] and unbound.

• The unbound drug is also called free [Free].• The proportion (fraction) of drug that is free depends on

the specific drug affinity for plasma proteins.– This proportion is noted fu (from 0 to 1 or 0 to 100%) with u

meaning unbound

][

][

Total

Freefu

Page 5: The Michaelis Menten equation

5

Free vs total concentrations

• In PK, the most commonly used analytical methods measure the total (plasma) drug concentrations i.e. [Total=B+Free].

• As generally only the unbound part of a drug is available at the target site of action including pathogens, the assessment of blood and plasma protein binding is critical to evaluate the in vivo free concentrations of drug i.e. [Free].

Page 6: The Michaelis Menten equation

6

Computation of the Free concentration from total concentration

ionconcentratplasmaTotalfuionconcentratplasmaFree

Page 7: The Michaelis Menten equation

7

Determination of fu

KdB

Kdfu

max

FreeKd

FreeBBound

max

Page 8: The Michaelis Menten equation

8

Determination of Bmax & Kd

Page 9: The Michaelis Menten equation

9

Determination of fu

1

2

Chamber

Chamberfu

Page 10: The Michaelis Menten equation

10

Determination of fu

• A more advanced protocol consists in repeating this kind of experiment but with very different values of drug concentrations in order to exhibit a possible saturation of the tested proteins.

Page 11: The Michaelis Menten equation

11

Data to analyse

Page 12: The Michaelis Menten equation

12

Plot of data

Linear portion

Page 13: The Michaelis Menten equation

13

Equation to fit

• Where NS is the proportionality costant for the Non Saturable binding

FreeNSFreeKd

FreeBFreeTotal

max

Page 14: The Michaelis Menten equation

14

Estimation of Bmax, Kd and NS using Non-Linear regression

• MODEL• remark ******************************************************• remark Developer: PL Toutain• remark Model Date: 03-29-2011• remark Model Version: 1.0• remark ******************************************************• remark• remark - define model-specific commands • COMMANDS • NSECO 3• NFUNCTIONS 1• NPARAMETERS 3• PNAMES 'Bmax', 'Kd', 'NS'• SNAMES 'fu5', 'fu100','fu1000'• END• remark - define temporary variables• TEMPORARY • Free=x• END • remark - define algebraic functions• FUNCTION 1• F= Free+(Bmax*Free)/(Kd+Free)+NS*Free• END• SECO• remark: free fraction for free=5 or 100 ng/ml• fu5=5/(5+(5*Bmax)/(kd+5)+NS*5)*100• fu100=100/(100+(100*Bmax)/(kd+100)+NS*100)*100• fu1000=1000/(1000+(100*Bmax)/(kd+1000)+NS*1000)*100• END• • remark - define any secondary parameters• remark - end of model• EOM

Page 15: The Michaelis Menten equation

15

The command block

• COMMANDS

• NSECO 3

• NFUNCTIONS 1

• NPARAMETERS 3

• PNAMES 'Bmax', 'Kd', 'NS'

• SNAMES 'fu5', 'fu100','fu1000'

• END

Page 16: The Michaelis Menten equation

16

The temporary block

• TEMPORARY

• Free=x

• END

Page 17: The Michaelis Menten equation

17

The function block

• FUNCTION 1• F= Free+(Bmax*Free)/(Kd+Free)+NS*Free• END

Page 18: The Michaelis Menten equation

18

The SECONDARY block

• SECO• remark: free fraction for free=5 or 100 ng/ml• fu5=5/(5+(5*Bmax)/(kd+5)+NS*5)*100• fu100=100/(100+(100*Bmax)/

(kd+100)+NS*100)*100•

fu1000=1000/(1000+(100*Bmax)/(kd+1000)+NS*1000)*100

• END

Page 19: The Michaelis Menten equation

19

Results

Page 20: The Michaelis Menten equation

20

Linearization of the MM equation

• Before nonlinear regression programs were available, scientists transformed data into a linear form, and then analyzed the data by linear regression. There are numerous methods to linearize binding data; the two most popular are the methods of Lineweaver-Burke and the Scatchard/Rosenthal plot.

Page 21: The Michaelis Menten equation

21

Linearization of the MM equation

• The Lineweaver Burke transformation

max

11

maxmax][

1

BFreeB

Kd

FreeB

FreeKd

B

Page 22: The Michaelis Menten equation

22

The Lineweaver Burke transformation

Page 23: The Michaelis Menten equation

23

Linear regression analysis of binding data

Page 24: The Michaelis Menten equation

24

Estimate parameters after transformation

Page 25: The Michaelis Menten equation

25

Pitfall of the linear regression analysis

• Now repeat your estimation of these two parameters (Bmax, Ka) by linear and non-linear regression but after altering a single value (replace the first value B=61.7 by B=50).